Bilateral risk-reducing salpingo-oophorectomy (BRRSO) is even more invasive, and it can be used to decrease the risk in BRCA2 carriers, as they can potentially develop breast cancers and ovarian neoplasms with a higher risk [11]. Here, BRCA2 is linked to breast cancer.